Form of words:
United Nations/Geneva: A spokesperson said a technical advisory group of the World Health Organization was reviewing data on Covaxin for India’s emergency use list of indigenous vaccines on Tuesday and it could make its decision within the next 24 hours.
Hyderabad-based Bharat Biotech, which has developed Covaxin, submitted the EOI (Expression of Interest) to the WHO on April 19 for the Emergency Use List (EUL) of the vaccine.
At COVAXIN, the technical advisory group that reviews all the data for the Potential Emergency Use Inventory is actually reviewing that data today. WHO official Dr Margaret Harris said during a press briefing that now if all is well, and all is well, and if the committee is satisfied, we would expect a recommendation within the next 24 hours.
Covaxin has demonstrated 77.8 percent effectiveness against symptomatic COVID-19 and 65.2 percent protection against the new Delta variant. In June, the company said it had finished the final analysis of Covaxin efficacy from Phase 3 trials.
Bharat Biotech’s Covaxin and AstraZeneca and Oxford University’s Covishield are two widely used vaccines in India.
WHO has so far approved Covid-19 vaccines from Pfizer-BioNtech, AstraZeneca-SK Bio/Serum Institute of India, Johnson & Johnson-Janssen, Moderna and Sinopharm for emergency use.
Last week, the WHO said it was expecting an additional information from Bharat Biotech about Covaxin and stressed that it is important to ensure that the vaccines are safe and to recommend the vaccine for emergency use. Can’t cut corners before, it has to be fully evaluated.
The UN health agency said the deadline for its emergency use list process depends on how quickly the vaccine maker will be able to evaluate the vaccine’s quality, safety, efficacy and its suitability for low and medium-term use by the WHO. able to provide the required data. income countries.
When all questions raised in the information provided are resolved, WHO and the technical advisory group will complete the assessment and come to a final recommendation on whether to list the vaccine for emergency use, it said.
Earlier, WHO Chief Scientist Soumya Swaminathan had said that the Technical Advisory Group at the WHO will meet on October 26 to consider the emergency use list for Covaxin.
“Technical Advisory Group will meet on 26 October to consider the EUL for #Covaxin. Working closely with @BharatBiotech to complete the @WHO dossier. We aim to have a broad portfolio of vaccines approved for emergency use and expand access to the population everywhere, she said.
read also: WHO will consider Covaxin’s emergency use list on 26 October
subscribe our channel youtube And Wire
Why is the news media in crisis and how can you fix it?
India needs free, unbiased, non-hyphenated and questionable journalism even more as it is facing many crises.
But the news media itself is in trouble. There have been brutal layoffs and pay-cuts. The best of journalism are shrinking, yielding to raw prime-time spectacle.
ThePrint has the best young journalists, columnists and editors to work for it. Smart and thinking people like you will have to pay a price to maintain this quality of journalism. Whether you live in India or abroad, you can Here.